Sec14 antibodies are predominantly polyclonal IgG antibodies developed against recombinant fragments of human SEC14L2 or homologs. Key features include:
These antibodies are validated for specificity through knockdown experiments. For example, SEC14L2 shRNA reduced protein levels in HEK293T cells, confirming antibody efficacy .
Sec14 antibodies enable critical investigations into lipid signaling and disease mechanisms:
Lipid Homeostasis: SEC14L2 regulates phosphatidylinositol (PI) transfer and PIP2 hydrolysis, impacting membrane lipid composition .
Wnt Signaling: Zebrafish Sec14l3 facilitates Wnt-Frizzled signaling by forming ternary complexes with Dishevelled and phospholipase C (PLCδ4a) .
Disease Associations: Mutations in SEC14 proteins correlate with neurodegenerative diseases (e.g., AVED) and photoreceptor dysfunction .
PIP2 Regulation: Depletion of SEC14L2 in HEK293T cells increased PIP2 levels at the plasma membrane, suggesting its role in PIP2 hydrolysis rather than transfer .
Structural Analysis: The Sec14 domain in Kalirin (a Rho-GEF) binds lysolipids via a surface groove, influencing membrane remodeling .
KEGG: spo:SPAC3H8.10
STRING: 4896.SPAC3H8.10.1
SEC14 proteins belong to a superfamily of phosphatidylinositol transfer proteins (PITPs) with the yeast Sec14p as the prototype. These proteins mediate critical cellular functions including membrane trafficking, phospholipid metabolism, and signaling pathways . Antibodies against SEC14 proteins are essential research tools that enable:
Detection and quantification of SEC14 proteins in various tissues and cell types
Investigation of subcellular localization and trafficking
Analysis of protein-protein and protein-lipid interactions
Functional characterization through immunodepletion studies
The SEC14 superfamily comprises over 500 members across eukaryotes, with several human paralogs (SEC14L2, SEC14L3, SEC14L4) implicated in disease processes, making antibodies against these proteins valuable for both basic and translational research .
Several types of SEC14 antibodies are available for research, including:
The selection of antibody depends on the specific experimental goals, target species, and application method .
To select the appropriate SEC14 antibody:
Identify your specific target protein (SEC14L2, SEC14L3, SEC14L4, or others)
Confirm species reactivity matches your experimental model
Verify application compatibility (WB, IF/ICC, IP, IHC)
Check validation data for your tissue/cell type of interest
Consider antibody format (unconjugated or conjugated)
For example, if studying SEC14L3 in mouse lung tissue via Western blot, the polyclonal antibody (32098-1-AP) would be appropriate as it has been validated in mouse lung tissue . For broader detection of multiple SEC14 family members, a pan-specific antibody like SEC14L2/L3/L4 (E-10) might be preferable .
For optimal Western blot results with SEC14 antibodies:
Sample preparation:
Electrophoresis and transfer:
Use 10-12% SDS-PAGE gels for SEC14 proteins (MW ~45-47 kDa)
Transfer to PVDF or nitrocellulose membranes
Immunoblotting:
Expected results:
Always include positive controls (e.g., mouse liver tissue for SEC14L3) to validate antibody performance .
For optimal immunofluorescence results with SEC14 antibodies:
Cell preparation:
Immunostaining:
Block with PBS containing 1% BSA and 0.02% Triton X-100
Incubate with primary antibody for 2 hours at room temperature
Wash with PBS containing 0.02% Triton X-100
Incubate with fluorescently-labeled secondary antibodies for 1 hour
Imaging:
SEC14 proteins typically show cytoplasmic localization with potential translocation to specific organelles depending on stimulation and cell type .
Several methodologies can be employed to study SEC14 protein-lipid interactions:
Lipid binding assays:
Phosphatidylinositol transfer assays:
Express and purify SEC14 proteins (e.g., using E. coli expression systems)
Measure transfer of fluorescently-labeled phospholipids between membranes
Quantify using fluorescence spectroscopy
GTPγS/GDP binding assays for SEC14 proteins with GTPase activity:
These methods have revealed that SEC14-like proteins such as Sec14l3 can bind GTP and interact with phospholipase C, mediating Wnt/Ca²⁺ signaling pathways .
SEC14 antibodies can be employed in several advanced approaches to elucidate their roles in signaling:
Immunoprecipitation coupled with mass spectrometry:
Use SEC14 antibodies to pull down protein complexes
Identify interacting partners through LC-MS/MS
Map protein interaction networks in different cellular contexts
Proximity labeling techniques:
Generate BioID or APEX2 fusion constructs with SEC14 proteins
Use SEC14 antibodies to validate expression and localization
Identify proximal proteins in living cells
Phosphoinositide signaling studies:
Research has demonstrated that SEC14-like proteins (Sec14l3/SEC14L2) can function as GTPase proteins to transduce Wnt signals from Frizzled to phospholipase C, revealing unexpected roles beyond phospholipid transfer .
To investigate SEC14 proteins in vesicular trafficking:
Genetic interaction studies:
Cargo trafficking assays:
Visualization of membrane trafficking:
Combine SEC14 immunostaining with markers of Golgi, endosomal, and plasma membrane compartments
Use live-cell imaging with fluorescently-tagged SEC14 proteins
Analyze colocalization and dynamics during vesicle formation and transport
Studies in yeast have shown that Sec14p controls specific trafficking pathways from the trans-Golgi network (TGN), with differential effects on various cargo proteins, suggesting pathway-specific regulation .
To investigate SEC14 proteins in disease contexts:
Expression profiling:
Use SEC14 antibodies for immunohistochemistry on disease tissue arrays
Quantify protein levels by Western blot in normal versus diseased samples
Correlate expression with clinical parameters and outcomes
Functional studies in disease models:
Employ SEC14 antibodies to validate knockdown or overexpression
Design rescue experiments with wild-type or mutant SEC14 proteins
Analyze phenotypic effects on disease-relevant cellular processes
Structure-function analysis:
SEC14 family proteins have been implicated in various diseases, including cancer, ataxia, and retinal degeneration, making them important targets for translational research .
Common challenges and solutions when working with SEC14 antibodies include:
Cross-reactivity between SEC14 family members:
Verify antibody specificity using knockout/knockdown controls
Use isoform-specific antibodies for discriminating between family members
Consider epitope mapping if uncertain about specificity
Low signal-to-noise ratio:
Optimize blocking conditions (try BSA instead of milk for phospho-specific detection)
Increase antibody concentration or incubation time
Use signal enhancement systems for low-abundance targets
Inconsistent results between applications:
Verify that the antibody is validated for your specific application
Adjust fixation methods for immunostaining (try different fixatives)
Test multiple antibody clones if available
Variable expression across tissues:
To maintain optimal activity of SEC14 antibodies:
Storage conditions:
Working solution preparation:
Dilute in fresh buffer immediately before use
For immunostaining, prepare in blocking buffer containing 1% BSA
For Western blot, prepare in 5% BSA or non-fat milk in TBST
Stability considerations:
Shipping and handling:
Upon receipt, immediately aliquot and store at recommended temperature
Avoid extended periods at room temperature
Follow manufacturer's specific recommendations
Recent research has uncovered unexpected functions of SEC14 proteins beyond classical phospholipid transfer:
GTPase activity:
Transcriptional regulation:
Immune response regulation:
These discoveries highlight the versatility of the SEC14 fold in translating biochemical interactions into diverse cellular functions.
Advanced biochemical techniques offering new insights into SEC14 proteins include:
Cryo-electron microscopy:
Determine high-resolution structures of SEC14 proteins in complex with binding partners
Visualize conformational changes upon ligand binding
Map interaction interfaces with unprecedented detail
Hydrogen-deuterium exchange mass spectrometry (HDX-MS):
Probe dynamic structural changes in SEC14 proteins upon lipid binding
Identify regions undergoing conformational shifts during activation
Map allosteric networks within the protein structure
Metal content analysis:
Isotopic labeling for structural studies:
These approaches are revealing unprecedented structural details about SEC14 proteins, including the discovery of a new class of fungal hemoproteins with the SEC14 fold .
Emerging translational applications for SEC14 antibodies include:
Biomarker development:
Evaluate SEC14 family protein expression in disease tissues
Correlate expression patterns with disease progression and outcomes
Develop diagnostic or prognostic assays based on SEC14 protein levels
Therapeutic target validation:
Use antibodies to validate SEC14 proteins as therapeutic targets
Study protein-protein interactions that could be disrupted by small molecules
Develop screening assays for inhibitor discovery
Antibody engineering:
Precision medicine approaches:
Stratify patients based on SEC14 protein expression patterns
Develop companion diagnostics for SEC14-targeting therapeutics
Identify patient populations most likely to benefit from SEC14-directed interventions